SK
Satya Kameswari Vakkalanka
About Satya Kameswari Vakkalanka
Data last updated:
Satya Kameswari Vakkalanka is a Director at Fenix Research Labs Private Limited (since 2008), Director at Sirak Pharmaceuticals Private Limited (since 2008) and Designated Partner at Zaian Remedies Llp (since 2025), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹14.58 Cr; the largest is Fenix Research Labs Private Limited at ₹11.62 Cr (FY 2025). Earlier, Satya Kameswari Vakkalanka was a Director at Zanthera Pharmaceuticals Private Limited (from 2007).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Aug 2008 | 2008 | ₹11.62 Cr (FY 2025) | Active | |
| Director | 08 Jan 2008 | 2008 | ₹2.97 Cr (FY 2024) | Active | |
| Designated Partner | 21 Feb 2025 | 2025 | Active | ||
| Designated Partner | 29 Apr 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Aug 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satya Kameswari Vakkalanka
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pranav Chirayu Amin | 00245099 | Fenix Research Labs Private Limited | Director |
| Shaunak Chirayu Amin | 00245523 | Fenix Research Labs Private Limited | Director |
| Thappali Ramaswamy Sethuraman Satheesh Manikandan | 08947176 | Fenix Research Labs Private Limited , Sirak Pharmaceuticals Private Limited | Director |
| Sita Samyukta Vakkalanka | 08947205 | Sirak Pharmaceuticals Private Limited , Sirak Research Labs Llp | Director |
| Swaroopkumar Venkata Satya Vakkalanka | 01737384 | Sirak Pharmaceuticals Private Limited , Zaian Remedies Llp | Director |
| Abhay Vishwasrao Muthal | 08630891 | Zaian Remedies Llp | Designated Partner |
| Shilpa Muthal | 09065460 | Zaian Remedies Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Kameswari Vakkalanka
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Kameswari Vakkalanka
Satya Kameswari Vakkalanka currently holds 4 directorships: Fenix Research Labs Private Limited (Director, since 30 Aug 2008, revenue ₹11.62 Cr (FY 2025)); Sirak Pharmaceuticals Private Limited (Director, since 08 Jan 2008, revenue ₹2.97 Cr (FY 2024)); Zaian Remedies Llp (Designated Partner, since 21 Feb 2025); Sirak Research Labs Llp (Designated Partner, since 29 Apr 2021).
Satya Kameswari Vakkalanka was first appointed on 08 Aug 2007 as Director at Zanthera Pharmaceuticals Private Limited. The most recent appointment on record is 21 Feb 2025 at Zaian Remedies Llp.
The 2 current companies of Satya Kameswari Vakkalanka that report revenue have a combined latest revenue of ₹14.58 Cr: Fenix Research Labs Private Limited ₹11.62 Cr (FY 2025); Sirak Pharmaceuticals Private Limited ₹2.97 Cr (FY 2024).
Satya Kameswari Vakkalanka held 1 earlier board appointment: Zanthera Pharmaceuticals Private Limited (Director, from 08 Aug 2007).
The current boards of Satya Kameswari Vakkalanka's companies include Pranav Chirayu Amin (Fenix Research Labs Private Limited), Shaunak Chirayu Amin (Fenix Research Labs Private Limited), Thappali Ramaswamy Sethuraman Satheesh Manikandan (Fenix Research Labs Private Limited), Sita Samyukta Vakkalanka (Sirak Pharmaceuticals Private Limited), Swaroopkumar Venkata Satya Vakkalanka (Sirak Pharmaceuticals Private Limited), Abhay Vishwasrao Muthal (Zaian Remedies Llp), among others.